Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY | BRISTOL MYERS SQUIBB CO | $96.74B | $45.01B | $18.19B | $8.03B | $3.88 | -2.50% | 14.81% | 30.64% | 5.21% | 2024-04-25 | |
JNJ | JOHNSON & JOHNSON | $348.72B | $85.16B | $45.15B | $35.15B | $13.88 | 6.46% | 0.86% | 103.22% | 19.48% | ||
GILD | GILEAD SCIENCES INC | $83.38B | $27.12B | $10.55B | $5.67B | $4.54 | -0.60% | 4.15% | 24.04% | 1.57% | 2024-04-25 | |
AZN | ASTRAZENECA PLC | $212.47B | $45.81B | $13.91B | $5.96B | $1.92 | 3.29% | 15.71% | 81.13% | 17.70% | 2024-04-25 | |
SNY | SANOFI | $116.64B | $49.94B | $14.09B | $5.81B | $2.32 | 6.87% | 4.70% | -32.73% | 3.84% | 2024-04-25 | |
GSK | GSK PLC | $80.31B | $38.39B | $8.20B | $6.24B | $3.08 | 8.66% | -0.37% | -65.61% | 5.64% | 2024-05-01 | |
NVS | NOVARTIS AG | $190.26B | $46.66B | $26.63B | $14.85B | $7.15 | 7.36% | 0.24% | 124.14% | 5.62% | 2024-04-23 | |
PFE | PFIZER INC | $143.54B | $58.50B | $7.29B | $2.12B | $0.38 | -41.70% | 7.46% | -93.20% | -27.52% | 2024-05-01 | |
BIIB | BIOGEN INC | $27.93B | $9.84B | $1.79B | $1.16B | $8.02 | -3.32% | -6.07% | -61.74% | -18.00% | 2024-04-24 | |
LLY | ELI LILLY & CO | $713.35B | $34.12B | $8.08B | $5.24B | $5.82 | 19.56% | 9.69% | -16.02% | 13.14% | 2024-04-30 | |
AMGN | AMGEN INC | $141.52B | $28.19B | $14.80B | $6.72B | $12.56 | 7.09% | 3.49% | 3.12% | -0.22% | 2024-05-02 | |
MRK | MERCK & CO INC | $317.52B | $60.12B | $6.90B | $365.00M | $0.14 | 1.40% | 7.29% | -97.56% | -43.06% | 2024-04-25 | |
ABBV | ABBVIE INC | $290.14B | $54.32B | $16.62B | $4.86B | $2.73 | -6.44% | 10.65% | -58.95% | -5.75% | 2024-04-26 | |
GRFS | GRIFOLS SA | $4.52B | $6.59B | $1.31B | $226.39M | $0.34 | 15.08% | 4.47% | 3.77% | -22.28% | 2024-05-02 | |
AMRN | AMARIN CORP PLC | $376.59M | $306.91M | -$50.70M | -$59.11M | -$0.15 | -16.87% | 6.01% | N/A | N/A | 2024-05-01 | |
OGN | ORGANON & CO | $4.57B | $6.26B | $1.44B | $1.02B | $4.01 | 1.44% | -8.52% | 11.08% | N/A | 2024-05-02 | |
SCLX | SCILEX HOLDING CO | $194.44M | $46.74M | -$108.60M | -$114.33M | -$1.28 | 22.90% | N/A | N/A | N/A |